Plasma Fractionation: Global Markets

Table of Contents

Chapter 1 introduction

Introduction
Study goals and objectives
Reasons for doing this study
Scope of report
Information sources
Methodology
Geographic breakdown
Analyst's credentials
Bcc custom research
Related bcc research reports

Chapter 2 summary and highlights

Chapter 3 market and technology background

Overview of plasma fractionation

• Classic fractionation methods (cohn fractionation)
• Components of blood plasma
• Functions of blood plasma
• Blood donation
• Collection and extraction of blood plasma
• Fractionation methods for extracting individual components of plasma
• Government funding of blood donation facilities
• Government regulations: fda, international regulatory agencies and medical associations
• Clinical guidelines

Chapter 4 impact of covid-19

Introduction
Outbreak
Progression of covid-19
Government expenditures on covid-19
Social impact of covid-19
Impact on insurance providers
Impact on health technology assessment

Chapter 5 market dynamics

Market drivers

• Overview
• Growing use of immunoglobulins in various therapeutic areas
• Growing prevalence of alpha-1 antitrypsin deficiency (aatd) and respiratory diseases
• Growing geriatric population
• Increase in blood donations

Market restraints

• High costs associated with plasma therapies
• Stringent government regulations and low reimbursement policies

Market opportunities

• Opportunities in emerging nations

Chapter 6 market breakdown by product

Global market for plasma fractionation by product

• Immunoglobulins
• Albumins
• Coagulation factor concentrates
• Others

Chapter 7 market breakdown by application

Global plasma fractionation market by application

• Neurology
• Immunology
• Hematology
• Others

Chapter 8 market breakdown by end user

Global plasma fractionation market by end user

• Hospitals and clinics
• Research laboratories
• Others

Chapter 9 market breakdown by region

Global market for plasma fractionation by region

• North america
• Europe
• Asia-pacific
• Latin america
• Middle east and africa

Chapter 10 competitive landscape

Global company ranking
Porter's five forces analysis

• Bargaining power of suppliers
• Bargaining power of buyers
• Threat of new entrants
• Threat of substitutes
• Competitive rivalry/degree of competition

Chapter 11 company profiles

Adma biologics inc.
Baxter
China biologic products inc.
Csl ltd.
Grifols s.a.
Kedrion spa
Octapharma ag

List of tables

Summary table a : global market for plasma fractionation, by product, through 2025
Summary table b : global market for plasma fractionation, by application, through 2025
Table 1 : blood plasma components
Table 2 : plasma constituents and their function
Table 3 : percentage of major proteins present in different fractions after cohn’s fractionation method
Table 4 : expenditures on covid-19 crisis, by country
Table 5 : interim economic outlook forecasts, by country/region, 2019-2021
Table 6 : use of immunoglobulin in hematology
Table 7 : use of immunoglobulin in neurology
Table 8 : use of immunoglobulin in infectious diseases
Table 9 : use of immunoglobulin in neurology
Table 10 : number and distribution of persons aged 60 and over, by region, 2017 and 2050
Table 11 : global market for plasma fractionation, by product, through 2025
Table 12 : global market for plasma fractionation of immunoglobulins, by region, through 2025
Table 13 : albumin products, by company
Table 14 : global market for plasma fractionation of albumin, by region, through 2025
Table 15 : global market for plasma fractionation of coagulation factor concentrates, by region, through 2025
Table 16 : global market for plasma fractionation of other products, by region, through 2025
Table 17 : global market for plasma fractionation, by application, through 2025
Table 18 : global market for plasma fractionation in neurology, by region, through 2025
Table 19 : global market for plasma fractionation in immunology, by region, through 2025
Table 20 : global market for plasma fractionation in hematology, by region, through 2025
Table 21 : global market for plasma fractionation of other applications, by region, through 2025
Table 22 : global market for plasma fractionation, by end user, through 2025
Table 23 : global market for plasma fractionation in hospital and clinics, by region, through 2025
Table 24 : global market for plasma fractionation in research laboratories, by region, through 2025
Table 25 : global market for plasma fractionation used by other end users, by region, through 2025
Table 26 : global market for plasma fractionation, by region, through 2025
Table 27 : north american market for plasma fractionation, by product, through 2025
Table 28 : north american market for plasma fractionation, by country, through 2025
Table 29 : european market for plasma fractionation, by product, through 2025
Table 30 : european market for plasma fractionation, by country/region, through 2025
Table 31 : asia-pacific market for plasma fractionation, by product, through 2025
Table 32 : asia-pacific market for plasma fractionation, by country/region, through 2025
Table 33 : japanese market statistics
Table 34 : latin american market for plasma fractionation, by product, through 2025
Table 35 : middle eastern and african market for plasma fractionation, by product, through 2025
Table 36 : global company ranking in the market for plasma fractionation, 2019
Table 37 : porter's five forces analysis
Table 38 : adma biologics inc.: products and services
Table 39 : adma biologics inc.: recent developments, 2017-2020
Table 40 : baxter: products and services
Table 41 : china biologic products holdings inc.: products and services
Table 42 : china biologic products holdings inc.: pipeline plasma products
Table 43 : china biologic products holdings inc.: recent developments, 2017
Table 44 : csl ltd.: products and services
Table 45 : csl ltd.: recent developments, 2017-2020
Table 46 : grifols, s.a.: products and services
Table 47 : grifols, s.a..: recent developments, 2017-2020
Table 48 : kedrion spa: products and services
Table 49 : kedrion spa: recent developments, 2017-2020
Table 50 : octapharma ag: products and services
Table 51 : octapharma ag: recent developments, 2020

List of figures

Summary figure a : global market shares for plasma fractionation, by product, 2019
Summary figure b : global market shares for plasma fractionation, by application, 2019
Figure 1 : comparison of gdp growth, by countries, 2019 and 2020
Figure 2 : fda regulation for approval of blood products and devices
Figure 3 : global market shares for plasma fractionation, by product, 2019
Figure 4 : immunoglobulin products
Figure 5 : categorization of subcutaneous immunoglobulin
Figure 6 : global market for plasma fractionation of immunoglobulins, 2018-2025
Figure 7 : global market for plasma fractionation of immunoglobulins, by region, 2018-2025
Figure 8 : global market for plasma fractionation of albumin, 2018-2025
Figure 9 : global market for plasma fractionation of albumin, by region, 2018-2025
Figure 10 : global market for plasma fractionation of coagulation factor concentrates, 2018-2025
Figure 11 : global market for plasma fractionation of coagulation factor concentrates, by region, 2018-2025
Figure 12 : global market for plasma fractionation of other products, 2018-2025
Figure 13 : global market for plasma fractionation of other products, by region, 2018-2025
Figure 14 : global market shares for plasma fractionation, by application, 2019
Figure 15 : global market for plasma fractionation in neurology, 2018-2025
Figure 16 : global market for plasma fractionation in neurology, by region, 2018-2025
Figure 17 : global market for plasma fractionation in immunology, 2018-2025
Figure 18 : global market for plasma fractionation in immunology, by region, 2018-2025
Figure 19 : global market for plasma fractionation in hematology, 2018-2025
Figure 20 : global market for plasma fractionation in hematology, by region, 2018-2025
Figure 21 : global market for plasma fractionation of other applications, 2018-2025
Figure 22 : global market for plasma fractionation of other applications, by region, 2018-2025
Figure 23 : global market shares for plasma fractionation, by end user, 2019
Figure 24 : global market for plasma fractionation in hospital and clinics, 2018-2025
Figure 25 : global market for plasma fractionation in hospital and clinics, by region, 2018-2025
Figure 26 : global market for plasma fractionation in research laboratories, 2018-2025
Figure 27 : global market for plasma fractionation in research laboratories, by region, 2018-2025
Figure 28 : role of platelet-rich plasma in treatment
Figure 29 : global market for plasma fractionation used by other end users, 2018-2025
Figure 30 : global market for plasma fractionation used by other end users, by region, 2018-2025
Figure 31 : global market for plasma fractionation, by region, 2018-2025
Figure 32 : global market shares for plasma fractionation, by region, 2019
Figure 33 : north american market shares for plasma fractionation, by product, 2019
Figure 34 : north american market shares for plasma fractionation, by country, 2019
Figure 35 : u.s. Market for plasma fractionation, 2019-2025
Figure 36 : canadian market for plasma fractionation, 2019-2025
Figure 37 : european market shares for plasma fractionation, by product, 2019
Figure 38 : european market shares for plasma fractionation, by country/region, 2019
Figure 39 : german market for plasma fractionation, 2019-2025
Figure 40 : french market for plasma fractionation, 2019-2025
Figure 41 : u.k. Market for plasma fractionation, 2019-2025
Figure 42 : italian market for plasma fractionation, 2019-2025
Figure 43 : spanish market for plasma fractionation, 2019-2025
Figure 44 : rest of european market for plasma fractionation, 2019-2025
Figure 45 : asia-pacific market shares for plasma fractionation, by product, 2019
Figure 46 : asia-pacific market shares for plasma fractionation, by country/region, 2019
Figure 47 : chinese market for plasma fractionation, 2019-2025
Figure 48 : japanese market for plasma fractionation, 2019-2025
Figure 49 : indian market for plasma fractionation, 2019-2025
Figure 50 : australian market for plasma fractionation, 2019-2025
Figure 51 : south korean market for plasma fractionation, 2019-2025
Figure 52 : rest of asia-pacific market for plasma fractionation, 2019-2025
Figure 53 : latin american market for plasma fractionation, 2019-2025
Figure 54 : latin american market shares for plasma fractionation, by product, 2019
Figure 55 : middle eastern and african market for plasma fractionation, 2019-2025
Figure 56 : middle eastern and african market shares for plasma fractionation, by product, 2019
Figure 57 : adma biologics inc.: financials, 2015-2019
Figure 58 : adma biologics inc.: revenue share, by business segment, 2019
Figure 59 : baxter: annual revenue, 2015-2019
Figure 60 : baxter: revenue share, by business unit, 2019
Figure 61 : baxter: revenue share, by region, 2019
Figure 62 : china biologic products holdings inc.: financials, 2015-2019
Figure 63 : china biologic products holdings inc.: revenue share, by segment, 2019
Figure 64 : csl ltd.: financials, 2015-2019
Figure 65 : csl ltd.: revenue share, by segment, 2019
Figure 66 : csl ltd.: revenue share, by country/region, 2019
Figure 67 : grifols s.a.: financials, 2015-2019
Figure 68 : grifols s.a.: revenues share, by segment, 2019
Figure 69 : grifols s.a.: revenue share, by country/region, 2019
Figure 70 : kedrion spa: financials, 2015-2019
Figure 71 : kedrion spa: revenue share, by segment, 2019
Figure 72 : kedrion spa: revenue share, by country/region, 2019
Figure 73 : octapharma ag: financials, 2015-2019
Figure 74 : octapharma ag: revenue, by operating income, 2015-2019

当レポートのプレスリリースは発行されておりません。